UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 22, 2005
VITAL SIGNS, INC.
(Exact Name of Registrant as Specified in its Charter)
New Jersey 0-18793 11-2279807
-------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
20 Campus Road, Totowa, New Jersey 07512
-------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (973) 790-1330
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On November 22, 2005, Vital Signs, Inc. (the "Company") issued a press
release regarding results for the three months and fiscal year ended September
30, 2005. A copy of this press release (the "Earnings Release") is being
furnished as Exhibit 99.1 to this Current Report on Form 8-K.
This Current Report on Form 8-K and the press release attached hereto are
being furnished to the Commission inasmuch as they disclose historical
information regarding the Company's results of operations for the three months
and fiscal year ended September 30, 2005 and statement of condition as of
September 30, 2005. Item 7.01 Regulation FD Disclosure.
Item 7.01 Regulation FD Disclosure
On November 22, 2005, the Company issued a second press release regarding
guidance for the year ending September 30, 2006. A copy of this press release
(the "Guidance Release") is being furnished as Exhibit 99.2 to this Current
Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits.
As described in Items 2.02 and 7.01 of this Report, the following Exhibits
are furnished as part of this Current Report on Form 8-K:
Exhibit 99.1: Earnings Release, dated November 22, 2005.
Exhibit 99.2: Guidance Release, dated November 22, 2005
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VITAL SIGNS, INC.
By: /s/ Jay Sturm
------------------------------------
Name: Jay Sturm
Title: Vice President / General Counsel
Dated: November 22, 2005
-3-
EXHIBIT INDEX
Exhibit No. Description
---------- -----------
99.1 Earnings Release, dated November 22, 2005
99.2 Guidance Release, dated November 22, 2005
-4-
STATEMENT OF DIFFERENCES
------------------------
The trademark symbol shall be expressed as .............................. 'TM'